Comparative Effectiveness of Dry Cupping and Graston Techniques in Scapulocostal Syndrome. (CMR = Compress)

December 22, 2025 updated by: Danyal Ahmad, University of Management and Technology Sialkot Pakistan

Comparative Effectiveness of Dry Cupping and Graston Techniques in Office Workers With Scapulocostal Syndrome; A Randomised Clinical Trail

The goal of this clinical trial is to check the comparative effectiveness of Graston Techniques and Dry cupping in Office Workers with Scapulocostal syndrome. The main questions it aims to answer are:

  1. To evaluate the relative effectiveness of dry cupping and the Graston technique.
  2. How well each technique reduces symptoms and enhances work productivity and functional outcomes.
  3. To assess whether integrating either Graston Technique or Dry Cupping provides more beneficial effects than conventional treatment alone.

1) Be divided into 2 Groups (Group A= Dry Cupping; B: Graston Techniques) 2) get the treatment for 4 weeks (3 days a week). 3) Receive the same conventional treatment.

Study Overview

Detailed Description

This study aims to compare the effectiveness of Graston and Dry cupping in treating Scapulocostal syndrome in office workers, focusing on specific outcomes like pain severity, functional outcomes, and work productivity.

This study will be a randomized clinical trial with a sample size of 46 participants with work-related SCS. The participants will be obtained by non-probability convenient sampling based on the inclusion and exclusion criteria. Participants will be randomly assigned into two groups, with 23 subjects in each group. Group A will receive dry cupping along with conventional therapy while Group B will receive IASTM along with conventional therapy.

Study Type

Interventional

Enrollment (Actual)

46

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lahore, Pakistan, 54910
        • Bethania Hospital
      • Sialkot, Pakistan, 54000
        • University of Management and technology Sialkot Campus
      • Sialkot, Pakistan
        • Bethania Hospital
    • Punjab Province
      • Sialkot, Punjab Province, Pakistan, 51310
        • Bethania Hospital Sialkot

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. 18-30 age group
  2. Males and females
  3. Office Workers.
  4. Subjects that have symptoms of musculoskeletal nature (
  5. Subjects with pain lasting for longer than 3 months (

Exclusion Criteria:

  1. Subjects with underlying pathology such as TOS, brachial neuralgia, cervical radiculopathy, polymyositis or Fibro myositis
  2. Subjects with systemic diseases such as rheumatoid arthritis, ankylosing spondylitis
  3. Subjects with the presence of any fractures
  4. Heart/diabetic patients
  5. Pregnant women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A = Dry Cupping
Group A will receive Dru cupping along with conventional treatment.
Dry cupping, originating in Middle Eastern and Asian countries, gained popularity in the United States after the 2016 Summer Olympics. It has two main forms: wet and dry cupping. Wet cupping involves laceration of the skin, while dry cupping uses negative pressure to pull the skin into the cup. Cupping is used to reduce musculoskeletal or myofascial pain, with the most accepted mechanism being localized hyperemia, which improves microcirculation and promotes healing
Experimental: Group B = Graston Technique
Group B will receive Graston Technique with Conventional treatment.
Instrument-assisted soft tissue mobilization (IASTM), derived from Cyriax cross-friction massage, is a popular alternative to traditional manual therapy techniques, with its first controlled study published in 1997 (Seffrin & Gardiner-Shires, 2019) .The Graston Technique(GT), also known as instrument-assisted soft tissue mobilization (IASTM), is used by chiropractors, doctors, and therapists to alleviate pain and range-of-motion restrictions caused by musculoskeletal injuries and scar tissue. (McKivigan, J. M., & Tulimero, G. et al. , 2020) . The Graston technique, is also used to alleviate upper cervical pain.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change From Baseline in Pain Intensity as Measured by the Visual Analog Scale
Time Frame: 4 Weeks
Pain intensity will be measured using the Visual Analog Scale (VAS), a 100 mm horizontal line anchored by two extremes: 0 mm represents "no pain" and 100 mm represents "worst imaginable pain." Participants will mark the point that best represents their pain intensity. The score is the distance in millimeters from the left end to the mark. Change in pain intensity will be calculated by subtracting the Week 4 score from the baseline score. A decrease in VAS score indicates an improvement in pain levels.
4 Weeks
Cervical Range of Motion (ROM)
Time Frame: 4 weeks
Cervical spine Range of Motion (ROM) will be assessed and measured using a universal goniometer by utilizing moving and stationary arm of angles in cervical spine range of motion..
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neck Disability Index (NDI) Total Score
Time Frame: 4 Weeks
The Neck Disability Index (NDI) is a validated 10-item questionnaire assessing neck-specific disability. Each item is scored from 0 to 5, resulting in a total score range of 0 to 50. Higher scores indicate greater disability. The change in total NDI score from baseline to Week 4 will be calculated. A decrease in score indicates clinical improvement.
4 Weeks
Treatment-Related Adverse Events During the 4-Week Intervention
Time Frame: 4 weeks
Treatment-related adverse events (AEs), such as skin irritation, bruising, or discomfort, will be recorded throughout the study. The number of participants experiencing at least one AE will be counted. All AEs will be assessed for severity and relatedness to the intervention.
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Danyal Ahmad, PhD Scholar, University of Management and Technology Sialkot Pakistan

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2024

Primary Completion (Actual)

January 25, 2025

Study Completion (Actual)

September 13, 2025

Study Registration Dates

First Submitted

November 18, 2024

First Submitted That Met QC Criteria

July 31, 2025

First Posted (Actual)

August 3, 2025

Study Record Updates

Last Update Posted (Actual)

December 30, 2025

Last Update Submitted That Met QC Criteria

December 22, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Individual Participant Data (IPD) will not be shared, or may not be shared, due to concerns regarding participant confidentiality and privacy, limitations of informed consent that did not explicitly include data sharing, and the risk of re-identification even after anonymization.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Scapulocostal Syndrome

Clinical Trials on Experimental: Group A = Dry Cupping

Subscribe